177Lu-PSMA617 and the VISION Trial: One of the Greatest Success Stories in the History of Nuclear Medicine

Volume: 62, Issue: 8, Pages: 1025 - 1026
Published: Jun 24, 2021
Abstract
The recently published results of the VISION trial ([1][1]) represent the culmination of translational research efforts that started in the 1980s and early 1990s with the discovery of the prostate-specific membrane antigen (PSMA) ([2][2]). Because of favorable biodistribution and tissue...
Paper Details
Title
177Lu-PSMA617 and the VISION Trial: One of the Greatest Success Stories in the History of Nuclear Medicine
Published Date
Jun 24, 2021
Volume
62
Issue
8
Pages
1025 - 1026
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.